CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS
Clinical trials for CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to halt liver scarring in hepatitis b and fatty liver patients
Disease control Recruiting nowThis study tests a drug called hydronidone in 200 adults with liver fibrosis caused by chronic hepatitis B or fatty liver disease. Participants take three capsules three times daily for 28 days. The main goal is to check for side effects, not to measure how well the drug works.
Matched conditions: CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS
Phase: PHASE2 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New liver drug safety trial begins for hepatitis b scarring
Disease control Recruiting nowThis study tests a drug called hydronidone in 300 adults with liver scarring (fibrosis or cirrhosis) from chronic hepatitis B. Participants take the drug three times daily for 28 days to see if it is safe. The main goal is to track any side effects.
Matched conditions: CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS
Phase: PHASE3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC